Literature DB >> 18222496

Cerebral ischemia: models, methods and outcomes.

Konstantin-Alexander Hossmann1.   

Abstract

Experimental research into brain ischemia contributes substantially to the understanding of ischemic injury mechanisms but suffers from its limited relevance for clinical treatment strategies. One of the reasons is the use of experimental models and methods that do not or only partially replicate the pathophysiology of naturally occurring brain ischemia. To facilitate the understanding and interpretation of experimental data, the most widely used experimental models and analytical methods of brain ischemia are reviewed. Particular emphasis is given to the pathophysiological particularities of the various ischemia models, the application of imaging methods for the reliable differentiation between infarct core, penumbra, benign oligemia and normal tissue, as well as to the final outcome of experimental interventions. Based on this analysis, recommendations are given to improve the translational power of brain ischemia-related experimental research.

Entities:  

Mesh:

Year:  2007        PMID: 18222496     DOI: 10.1016/j.neuropharm.2007.12.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  58 in total

1.  The two pathophysiologies of focal brain ischemia: implications for translational stroke research.

Authors:  Konstantin-Alexander Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-11       Impact factor: 6.200

Review 2.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

3.  Effects of hypoxia, glucose deprivation and recovery on the expression of nucleoside transporters and adenosine uptake in primary culture of rat cortical astrocytes.

Authors:  Zoran B Redzic; Slava A Malatiali; Maie Al-Bader; Hameed Al-Sarraf
Journal:  Neurochem Res       Date:  2010-06-25       Impact factor: 3.996

4.  Precision Stroke Animal Models: the Permanent MCAO Model Should Be the Primary Model, Not Transient MCAO.

Authors:  Devin W McBride; John H Zhang
Journal:  Transl Stroke Res       Date:  2017-07-17       Impact factor: 6.829

Review 5.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

6.  Uncoupling of neurovascular communication after transient global cerebral ischemia is caused by impaired parenchymal smooth muscle Kir channel function.

Authors:  Gro Klitgaard Povlsen; Thomas A Longden; Adrian D Bonev; David C Hill-Eubanks; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-04-06       Impact factor: 6.200

7.  A Critical Re-Examination of the Intraluminal Filament MCAO Model: Impact of External Carotid Artery Transection.

Authors:  Rebecca C Trueman; David J Harrison; Dominic M Dwyer; Stephen B Dunnett; Mathias Hoehn; Tracy D Farr
Journal:  Transl Stroke Res       Date:  2011-08-16       Impact factor: 6.829

8.  Association between changes in weight and cerebral arteries in rats.

Authors:  Afshin A Divani; Ankur Patel; Vance L Fredrickson; Blake Siljander; Gabriela Vazquez
Journal:  Transl Stroke Res       Date:  2010-03-02       Impact factor: 6.829

Review 9.  Translational MR Neuroimaging of Stroke and Recovery.

Authors:  Emiri T Mandeville; Cenk Ayata; Yi Zheng; Joseph B Mandeville
Journal:  Transl Stroke Res       Date:  2016-08-31       Impact factor: 6.829

10.  Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.

Authors:  Anna Tietze; Jakob Blicher; Irene Klaerke Mikkelsen; Leif Østergaard; Megan K Strother; Seth A Smith; Manus J Donahue
Journal:  NMR Biomed       Date:  2013-11-28       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.